Joint venture gives Sanofi-Aventis a toe-hold in Japan's generics sector
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis's plans to develop its generics business in Japan have taken a step forward through an agreement to set up a joint venture with Nichi-Iko Pharmaceutical, a leading local firm in the sector.